文献
J-GLOBAL ID:202202227505510464
整理番号:22A0981213
ファーマコゲノミクス試験の>1500名の患者における抗癌処方のための臨床作用性遺伝子型【JST・京大機械翻訳】
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing
著者 (23件):
Reizine Natalie M.
(Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
Reizine Natalie M.
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
Danahey Keith
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
Danahey Keith
(Center for Research Informatics, University of Chicago, Chicago, Illinois)
,
Truong Tien M.
(Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
Truong Tien M.
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
George David
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
George David
(Department of Pathology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
House Larry K.
(Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
House Larry K.
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
Karrison Theodore G.
(Department of Public Health Sciences, University of Chicago, Chicago, Illinois)
,
van Wijk Xander M. R.
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
van Wijk Xander M. R.
(Department of Pathology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
van Wijk Xander M. R.
(Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois)
,
Yeo Kiang-Teck J.
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
Yeo Kiang-Teck J.
(Department of Pathology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
Yeo Kiang-Teck J.
(Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois)
,
Ratain Mark J.
(Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
Ratain Mark J.
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
Ratain Mark J.
(Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois)
,
O’Donnell Peter H.
(Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois)
,
O’Donnell Peter H.
(Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois)
,
O’Donnell Peter H.
(Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
128
号:
8
ページ:
1649-1657
発行年:
2022年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)